Sort
15,440 grants matching “organoids”
Longitudinal models of breast cancer for studying mechanisms of therapy response and resistance
$986,128Bryan E. Welm · University Of Utah · U01 · FY2020 · CA
The role of stem cells and the microenvironment in gastrointestinal cancers
$986,058Timothy Cragin Wang · Columbia University Health Sciences · R35 · FY2025 · CA
Mitigation of Radiation Induced Gastrointestinal Syndrome.
$985,537Andrew John Norris · Bcn Biosciences, Llc · R44 · FY2025 · AI
Stromal modulation of pancreatic cancer malignant cell state and therapeutic sensitivity
$985,172William C Hahn · Dana-Farber Cancer Inst · U01 · FY2024 · CA
Epitranscriptomic regulation in the mammalian nervous system
$985,026Guo-Li Ming · University Of Pennsylvania · R35 · FY2025 · NS
A single antiviral to treat multiple opportunistic infections
$983,882Stacy Remiszewski · Evrys Bio, Llc · R44 · FY2024 · AI
University of Michigan Center for Gastrointestinal Research
$983,685John W Wiley · University Of Michigan At Ann Arbor · P30 · FY2021 · DK
Minerals in Nutrition and Development
$982,544Rajini Rao · Johns Hopkins University · UC2 · FY2023 · HD
Pathway Discovery and Target Validation for Outgrowth of Breast Cancer Metastases
$982,500Joel S. Bader · Johns Hopkins University · U01 · FY2021 · CA
Pathway Discovery and Target Validation for Outgrowth of Breast Cancer Metastases
$982,500Joel S. Bader · Johns Hopkins University · U01 · FY2020 · CA
Dynamic RNA Modifications in human brain development and autism
$981,614Peng Jin · Emory University · U01 · FY2020 · MH
Comprehensive validation and commercial readiness of SpliceIO, a software platform for neoantigen discovery using RNA-seq data
$980,257Martin Akerman · Envisagenics, Inc. · R44 · FY2023 · CA
Development of SUMO1 small molecule degraders as the first-in-class anticancerdrugs for metastatic colorectal cancer
$979,536Anita Bellail · Hb Therapeutics, Inc. · R44 · FY2023 · CA
A single antiviral to treat multiple opportunistic infections
$978,771Stacy Remiszewski · Evrys Bio, Llc · R44 · FY2025 · AI
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer
$978,122Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Macrophage Polarization in Response to Infections and Inflammation
$978,019Pradipta Ghosh · University Of California, San Diego · R01 · FY2022 · AI
Shigella Live Vector-Based Multivalent Vaccine
$975,452Eileen M. Barry · University Of Maryland Baltimore · U19 · FY2015 · AI
University of Michigan Center for Gastrointestinal Research
$975,352Chung Owyang · University Of Michigan At Ann Arbor · P30 · FY2018 · DK
Cell plasticity in the origin of gastric carcinogenesis
$975,011Eunyoung Choi · Vanderbilt University Medical Center · R01 · FY2024 · CA
Metabolic Influences on Complex Tumor Neighborhoods
$975,000M. Celeste Simon · University Of Pennsylvania · R35 · FY2025 · CA
"A Novel Role for the UPR Component, ATF6 in AD-associated Neuroprotective Pathways"
$974,957Randal J. Kaufman · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2023 · AG
Pathway Discovery and Target Validation for Outgrowth of Breast Cancer Metastases
$974,850Joel S. Bader · Johns Hopkins University · U01 · FY2018 · CA
"A Novel Role for the UPR Component, ATF6 in AD-associated Neuroprotective Pathways"
$974,758Randal J. Kaufman · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · AG
"A Novel Role for the UPR Component, ATF6 in AD-associated Neuroprotective Pathways"
$973,393Randal J. Kaufman · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · AG
Minerals in Nutrition and Development
$972,718Rajini Rao · Johns Hopkins University · UC2 · FY2024 · HD